Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,398.00
Bid: 12,398.00
Ask: 12,402.00
Change: 58.00 (0.47%)
Spread: 4.00 (0.032%)
Open: 12,414.00
High: 12,414.00
Low: 12,300.00
Prev. Close: 12,340.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-WHO expects decisions on Pfizer, Moderna, AstraZeneca vaccines in weeks

Fri, 11th Dec 2020 17:28

(Adds background, details, quotes from WHO officials)

GENEVA, Dec 11 (Reuters) - The World Health Organization
expects to make decisions on whether to give emergency use
approval to COVID-19 vaccines from Pfizer, Moderna and
AstraZeneca in the coming weeks, its chief scientist said on
Friday.

Soumya Swaminathan said the global health body could decide
on Pfizer's vaccine candidate in the next "couple of
weeks", and later said it could also review Moderna's
and AstraZeneca's candidates in a few weeks.

WHO approval could allow a vaccine to be deployed in some
countries where national medical regulators have not yet been
able to evaluate it. Swaminathan said at least 10 companies had
expressed an interest in or submitted a request for emergency
approval for vaccine candidates.

Pfizer's vaccine has already received emergency approval in
Britain and Canada, and could receive U.S. approval within days.
The first British recipients were vaccinated this week.

WHO Director-General Tedros Adhanom Ghebreyesus said nearly
a billion doses of vaccines had been secured for the COVAX
programme to provide shots for poor- and middle-income
countries, with 189 countries participating.

WHO officials described the arrival of vaccines as a major
development, but stressed repeatedly that it would take a long
time before vaccines could be rolled out worldwide.

In the meantime, the epidemic is worsening in much of the
world, and countries must continue to take other steps to curb
infection, such as testing, tracing, isolating cases and social
distancing. Tedros noted that coronavirus deaths had increased
60% in the last six weeks.

Swaminathan said the supply of vaccines was likely to be
limited for the first half of 2021.

WHO emergencies director Mike Ryan said: "Vaccines represent
a major, major light at the end of the tunnel, but we have much
work to do to make that a reality."

Bruce Aylward, a senior adviser to Tedros, added: "It is a
long tunnel, to give it to you straight. It is a long tunnel."
(Reporting by Stephanie Nebehay, Emma Farge and Peter Graff
Writing by Peter Graff; Editing by Catherine Evans, Andrew
Heavens and Tom Brown)

More News
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.